Advertisement
The Brazilian made 49 appearances for Barcelona last season.

'Welcome back' - Barcelona midfielder Paulinho returns to Chinese Super League

Chinese Super League side Guangzhou Evergrande have announced the return of former midfielder Paulinho.

PAULINHO HAS RETURNED to the Chinese Super League, agreeing a move from Barcelona to Guangzhou Evergrande after less than a year in La Liga

The midfielder was a surprise arrival at Camp Nou last summer, arriving towards the end of the transfer window following the sale of Neymar.

He made a bright start to life at Barca, however, and while his form dipped later on he formed a key part of the team that won a domestic double in 2017-18.

In total the Brazilian made 49 appearances for Barcelona, scoring nine goals and adding a further three assists in all competitions.

With the Catalans struggling to accommodate a host of non-European Union players, however, Paulinho has been released back to Guangzhou.

“Welcome back,” Guangzhou wrote on their official website alongside a picture of the 29-year-old, who formed part of Brazil’s World Cup squad in Russia.

The player spent almost three years with the Chinese Super League club in his first spell, playing almost 100 games with the giants and lifting back-to-back CSL titles.

Paulinho’s exit will open up a spot for compatriot Arthur, who is set to join the Blaugrana from Gremio this summer.

Colombia’s Yerry Mina is another whose future appears uncertain at Camp Nou, with interest from Everton arising for the central defender.

The42 is on Instagram! Tap the button below on your phone to follow us!

Ronaldo move to Juventus could help Serie A recapture its former glory – Baptista

Croatia coach identifies Sterling as England’s danger man

Author
View 17 comments
Close
17 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel